News Release

Johns Hopkins professor Dr. Lisa A. Cooper named one of seven Distinguished Scientists

American Heart Association Scientific Sessions 2022

Grant and Award Announcement

American Heart Association

Embargoed until 7 a.m. CT / 8 a.m. ET Friday, Oct. 28, 2022

DALLAS, Oct. 28, 2022 – The American Heart Association is presenting one of its 2022 Distinguished Scientist awards to Lisa A. Cooper, M.D., M.P.H., FAHA (Hon.), of Johns Hopkins School of Medicine. The Association honors members who have significantly advanced the understanding of cardiovascular, stroke or brain health as Distinguished Scientists. Seven 2022 Distinguished Scientist awardees will be recognized during the Association’s Scientific Sessions 2022, which will held in person in Chicago and virtually Nov. 5-7.

Dr. Cooper’s work as a researcher has focused on the roles race and social class play in contributing to health disparities. Her work majorly influenced the communication methods health care professionals use when interacting with patients. Early in her career, her research pinpointed how differences between health care professionals and their patients, (e.g., gender, race, etc.) can create communication barriers that affect patient care. This discovery has influenced how patients are engaged as active members of their health care teams. Her work also includes extensive research on the effects of social inequality for patients struggling to manage heart disease or stroke.

Dr. Cooper conducts clinical trials that utilize community-based approaches to improve patient outcomes and increase health equity for patients with heart disease and stroke. In the past two years, Dr. Cooper has been called on to apply her expertise in health communications and community-based approaches to the COVID-19 pandemic.

Dr. Cooper is the James F. Fries Professor of Medicine and a Bloomberg Distinguished Professor at Johns Hopkins University Schools of Medicine, Nursing and Bloomberg School of Public Health. She is the founder and director of the Johns Hopkins Center for Health Equity. She is also a member of the core faculty at the Johns Hopkins Welch Center for Prevention, Epidemiology and Clinical Research, a senior advisor at the Johns Hopkins Armstrong Institute for Patient Safety and Quality and a faculty member of the Johns Hopkins Center for Health Disparities Solutions.

Dr. Cooper earned a bachelor’s degree in chemistry from Emory College and a Doctor of Medicine from the University of North Carolina at Chapel Hill. She earned a Master of Public Health focused on epidemiology and health policy from the Johns Hopkins University Bloomberg School of Public Health, and she is board-certified in internal medicine. She completed her residency at the University of Maryland Hospital and the Baltimore VA Medical Center, and completed a fellowship in internal medicine at the Johns Hopkins University School of Medicine.

She has published more than 250 peer-reviewed articles and serves on the editorial board of JAMA Health Forum Dr. Cooper is a member of the American Society for Clinical Investigation and the Association of American Physicians. She was recognized with a 2007 MacArthur Fellowship Award and elected to the National Academy of Medicine in 2008.

Dr. Cooper is immediate past co-chair of the steering committee for The Community Engagement Alliance Against COVID-19 Disparities at the National Institutes of Health, a member of the clinical trial diversity advisory board at Pfizer, Inc., and a member of the President’s Council of Advisors on Science and Technology.

Additional Resources:

The Association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific Association programs and events. The Association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and biotech companies, device manufacturers and health insurance providers and the Association’s overall financial information are available here

The American Heart Association’s Scientific Sessions 2022 is a premier global exchange of the latest scientific advancements, research and evidence-based clinical practice updates in cardiovascular science. The 3-day meeting will feature more than 500 sessions focused on breakthrough cardiovascular basic, clinical and population science updates occurring Saturday through Monday, November 5-7, 2022. Thousands of leading physicians, scientists, cardiologists, advanced practice nurses and allied health care professionals from around the world will convene virtually to participate in basic, clinical and population science presentations, discussions and curricula that can shape the future of cardiovascular science and medicine, including prevention and quality improvement. During the three-day meeting, attendees receive exclusive access to more than 4,000 original research presentations and can earn Continuing Medical Education (CME), Continuing Education (CE) or Maintenance of Certification (MOC) credits for educational sessions. Engage in Scientific Sessions 2022 on social media via #AHA22.

About the American Heart Association

The American Heart Association is a relentless force for a world of longer, healthier lives. We are dedicated to ensuring equitable health in all communities. Through collaboration with numerous organizations, and powered by millions of volunteers, we fund innovative research, advocate for the public’s health and share lifesaving resources. The Dallas-based organization has been a leading source of health information for nearly a century. Connect with us on heart.orgFacebookTwitter or by calling 1-800-AHA-USA1.  


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.